Literature DB >> 2642471

Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

P D Walzer1, C K Kim, M J Linke, C L Pogue, M J Huerkamp, C E Chrisp, A V Lerro, S K Wixson, E Hall, L D Shultz.   

Abstract

Outbreaks of Pneumocystis carinii pneumonia occurred in colonies of nu/nu and scid/scid mice at four different institutions. The disease, which was characterized by chronic wasting and respiratory insufficiency, was more severe in older mice and in animals housed in cages with special protective tops. Histopathologic features included alveolar filling with the typical foamy honeycomb material and a mild, nonspecific host inflammatory response. Immunofluorescence and immunoblotting studies suggested the P. carinii isolate was of mouse rather than of rat or human origin, and the outbreaks could be related to each other by common vendor or source of breeding animals. Once P. carinii became established in a mouse colony, the organism tended to persist for long periods of time. The principal control measure was depopulation of the colony, although limited experience with the administration of trimethoprim-sulfamethoxazole was encouraging. Thus, outbreaks of pneumocystosis are a serious problem among colonies of immunodeficient mice, with important implications for the use of these animals in biomedical research. Data obtained by studying these outbreaks should enhance understanding of the pathogenesis of P. carinii pneumonia and be helpful in formulating improved methods of detection and control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642471      PMCID: PMC313041          DOI: 10.1128/iai.57.1.62-70.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.

Authors:  W T Hughes; S Feldman; S C Chaudhary; M J Ossi; F Cox; S K Sanyal
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

4.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

5.  Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting.

Authors:  D C Graves; S J McNabb; M A Worley; T D Downs; M H Ivey
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

6.  Provocation experiment: Pneumocystis carinii in several kinds of animals.

Authors:  Y Yoshida; M Yamada; T Shiota; T Ikai; S Takeuchi; K Ogino
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981

Review 7.  Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS.

Authors:  J Mills
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Intra- and inter-species transmission and antigenic difference of Pneumocystis carinii derived from rat and mouse.

Authors:  T Furuta; K Ueda
Journal:  Jpn J Exp Med       Date:  1987-02

9.  Development and characterization of monoclonal antibodies to Pneumocystis carinii.

Authors:  D C Graves; S J McNabb; M H Ivey; M A Worley
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

10.  Experimental Pneumocystis carinii infection in nude rats.

Authors:  T Furuta; K Ueda; K Fujiwara
Journal:  Jpn J Exp Med       Date:  1984-04
View more
  22 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

Review 3.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

4.  Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection.

Authors:  Xiaowen L Rudner; Kyle I Happel; Erana A Young; Judd E Shellito
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

5.  Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

Authors:  M A Powles; D C McFadden; L A Pittarelli; D M Schmatz
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology.

Authors:  J B Roths; J D Marshall; R D Allen; G A Carlson; C L Sidman
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Experimental sialodacryoadenitis virus infection in severe combined immunodeficient mice.

Authors:  D H Percy; K L Williams; B A Croy
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  Exacerbation of Pneumocystis carinii pneumonia in immunodeficient (scid) mice by concurrent infection with a pneumovirus.

Authors:  M V Bray; S W Barthold; C L Sidman; J Roths; A L Smith
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice.

Authors:  D C McFadden; M A Powles; J G Smith; A M Flattery; K Bartizal; D M Schmatz
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.

Authors:  S A Theus; R P Andrews; P Steele; P D Walzer
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.